ExoticRx · exoticrx.com/drugs/ilunocitinib
US brand names:Greylan
Ilunocitinib is dosed at 0.6–1.8 mg/kg PO q24h in dogs, per FDA conditional approval data; FDA openFDA Adverse Event Database. Verify against current literature before clinical use.
Selective Janus kinase 1 (JAK1) inhibitor that blocks cytokine signaling pathways involved in pruritus and inflammation, reducing itch and allergic skin inflammation in dogs.
New veterinary JAK inhibitor with limited post-market data. Monitor CBC and liver values. May increase susceptibility to infections. Similar class warnings to oclacitinib.
Species references:All Dog (Domestic) drugs
Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.
A dog/cat sample is shown here. Cited dosing for all 1 species — reptiles, birds, pocket pets, livestock, and equine — is free on the per-species pages above. Pro adds the weight-based calculator for every species.
| Species | Route | Dose | Frequency | Evidence | Source |
|---|---|---|---|---|---|
| Dog (Domestic) | PO | 0.6–1.8 mg/kg | q24h | Moderate | FDA conditional approval data; FDA openFDA Adverse Event Database |
Upgrade to Pro or Student to unlock the full dose ranges and frequency for every species. The drug's mechanism, warnings, indications, and cited sources are free to read.
View PlansSource citations and evidence levels available on the live page. Reference only — verify against current literature before clinical use.